|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|
| Cash Flows from Operating Activities: | |||
| Net Income (loss) | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Interest earned on Investments held in trust Account | |||
| Changes in operating assets and liabilities: | |||
| Prepaid expenses | |||
| Accounts payable and accrued expenses | |||
| Due to Sponsor | |||
| Income tax payable | |||
| Franchise tax payable | |||
| Income tax receivable / payable | |||
| Franchise tax receivable / payable | |||
| Deferred offering costs | |||
| Net cash used in operating activities | |||
| Cash Flows from Investing Activities: | |||
| Investment of cash into Trust Account | |||
| Trust Account Withdrawal | |||
| Trust Account Withdrawal for redeeming stockholder payments | |||
| Trust Account Withdrawal for tax payments | |||
| Net cash provided by investing activities | |||
| Cash Flows from Financing Activities: | |||
| Proceeds from issuance of founder shares to Sponsor | |||
| Proceeds from sale of Units, net of underwriting discounts paid | |||
| Offering costs paid through IPO | |||
| Proceeds from sale of Private Placement Warrants | |||
| Proceeds from promissory note - related party | |||
| Proceeds from Sponsor for working capital | |||
| Payment to redeeming stockholders | |||
| Net cash used by financing activities | |||
| Net Change in Cash | |||
| Cash - Beginning of period | |||
| Cash - End of period | |||
| Supplemental cash flow information: | |||
| Cash paid for income taxes | |||
| Non-cash investing and financing activities: | |||
| Deferred offering costs included in accrued offering costs | |||
| Offering costs included in due to sponsor | |||
| Excise tax on stockholder redemption | |||
| Accretion of Class A common stock subject to possible redemption |
Loading...
